sub:assertion {
  d:DB08818 v:identifier "DB08818" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB08818" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB08818> ;
    dv:drugbank-id "DB08818" ;
    dv:x-atc <http://bio2rdf.org/atc:R01AX09> ;
    dv:x-cas <http://bio2rdf.org/cas:9067-32-7> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D03354> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA165958431> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Sodium_hyaluronate> ;
    dct:description "Sodium hyaluronate is the sodium salt of hyaluronan. The term hyaluronate also refers to the conjugate base of hyaluronic acid. Because the molecule typically exists in vivo in its polyanionic form, it is most commonly referred to as hyaluronan. It is a visco-elastic polymer normally found in the aqueous and vitreous humour. Sodium hyaluronate is a viscous solution consisting of a high molecular weight (500,000-730,000 daltons) fraction of purified natural sodium hyaluronate in buffered physiological sodium chloride. Hyaluronic acid is a natural complex sugar of the glycosaminoglycan family and is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. Sodium hyaluronate occurs naturally on the corneal endothelium, bound to specific receptors for which it has a high affinity."@en ;
    dct:identifier "drugbank:DB08818" ;
    dct:title "Hyaluronan"@en ;
    a dv:Drug ;
    rdfs:label "Hyaluronan [drugbank:DB08818]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB08818> .
}